{
    "title": "AstraZeneca's Lynparza slows advanced breast cancer progression -study",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-4570646/AstraZenecas-Lynparza-slows-advanced-breast-cancer-progression-study.html",
    "date": "2017-06-04",
    "keywords": [
        "percent",
        "cancer",
        "breast",
        "chemotherapy",
        "study",
        "lynparza",
        "time",
        "robson",
        "bill",
        "berkrot",
        "response",
        "disease",
        "progression",
        "brca1",
        "brca2",
        "versus",
        "york",
        "data",
        "parp",
        "drug",
        "june",
        "rate",
        "plcs",
        "latestage",
        "trial",
        "sunday",
        "treatment",
        "tumor",
        "shrinkage",
        "worsening",
        "reduction",
        "risk",
        "addition",
        "delay",
        "quality",
        "life",
        "mark",
        "sloan",
        "center",
        "hormone",
        "receptorpositive",
        "triple",
        "couple",
        "agent",
        "alternative",
        "society",
        "oncology",
        "asco",
        "meeting",
        "chicago",
        "class",
        "michelle",
        "head",
        "astrazeneca",
        "space",
        "company",
        "approval",
        "use",
        "end",
        "year",
        "im",
        "president",
        "dr",
        "ability",
        "dna",
        "side",
        "combination",
        "variety",
        "benefit",
        "reporting",
        "editing",
        "matthew",
        "lewis"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}